DSULABs · dark spots & uneven tone
A gentle cleanser and a richer moisturizing base. Explore the product notes and sunscreen choices before making a selection.
01 · Find a starting point
Skin type and sensitivity are separate. Each set still needs individual product and tolerance review.
Set 02 · proposed
A gentle cleanser and a richer moisturizing base.
Treatment is selected separately by pigmentation concern, tolerance, current products and safety checks. Sensitivity and current irritation are independent of skin type.
02 · Understand each formula
Open a product note to see the formula, the supporting evidence and the limits of what we can conclude.
Affiliate disclosure: As an Amazon Associate I earn from qualifying purchases. Retailer purchases take place outside DSULABs. Product notes are not ranked by commission.
Cleanser · gentle option
A soap-free cleanser for the cleansing step.
The manufacturer lists glycerin and non-soap surfactants. Its role in these draft sets is cleansing, without adding another targeted treatment.
This formula note is based on the manufacturer ingredient list. No direct dark-spot fading claim or personal-use result is proposed.
A sensitive-skin label cannot rule out an individual reaction. Keep an existing suitable cleanser if it already meets the person's needs.
Moisturizer · richer cream
A fragrance-free cream positioned for normal to dry skin.
The manufacturer identifies ceramides and hyaluronic acid. It is included as the richer alternative to a light facial lotion.
Its role here is moisturization. Ingredient presence does not support claiming that the cream clears pigmentation or guarantees treatment tolerance.
Review whether the richer texture fits the person's needs. Confirm the exact Moisturizing Cream variant when creating a retailer link.
Sunscreen · daily tinted option
Broad-spectrum SPF 30 with iron oxides in the Medium variant.
The Medium formula combines zinc oxide and titanium dioxide with a tint. Light and Deep manufacturer pages also exist; a suitable shade must be selected individually.
AAD guidance supports considering tinted sunscreen with iron oxides for dark-spot care. It does not quantify this particular formula's visible-light protection.
The brand directs users to a water-resistant sunscreen for swimming or sweating. Review current label cautions, including the listed salicylic-acid-related ingredients.
Sunscreen · untinted alternative
An untinted zinc-oxide facial moisturizer with broad-spectrum SPF 30.
The inspected ingredient list contains no iron oxides. It provides an untinted candidate for individual review, rather than an equivalent substitute for tint's visible-light coverage.
The DailyMed label directs users to a water-resistant sunscreen for swimming or sweating. It supports omitting a water-resistance claim while the conflicting manufacturer FAQ is resolved.
Confirm the current package and assess finish, including possible white cast, before recommending it.
Sunscreen · water-resistant tint candidate
SPF 50 tint with an 80-minute swimming/sweating reapplication interval.
The verified US page is Medium to Tan, 2.5 fl oz, manufacturer SKU A71005. It lists titanium dioxide, zinc oxide, iron oxides and eucalyptus extract.
The manufacturer directions support considering it for the water-resistant slot. No quantified visible-light protection or clinical pigmentation result is claimed.
Check the current package, broad-spectrum label, shade match and matte finish. Fragrance-free does not mean every person will tolerate its botanical ingredients.
Evidence before recommendations
We distinguish manufacturer ingredient information from human research on a finished formula. A study of another concentration or vehicle does not prove this product will produce the same result. These notes are formula analyses; no personal testing or outcome guarantee is claimed.
Dr. Sultan U., PharmD, PhD, is the founder of DSULABs.
He has 11 years of experience developing skincare ingredients for dark spots and more than six years of small-molecule drug-discovery research focused on neurodegenerative diseases. His research record includes more than 40 publications, and his neurodegenerative research has contributed to two patents.
Read our review methodology